Side-by-Side Comparison
| Metric | Genelux | Novocure |
|---|---|---|
| Founded | ||
| Founded | 2001 | 2000 older |
| Headquarters | ||
| Headquarters | Westlake Village, United States | Switzerland |
| Employees | ||
| Employees | 34 | 1384 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $98.98M | $1.07B |
| Funding Rounds | ||
| Funding Rounds | 5 | 7 |
| Services | ||
| Services | Development of oncolytic immunotherapy, Clinical trial management, Expanded access programs | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare professionals, Clinical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oncolytic Immunotherapy, Solid Tumors, Cancer Treatment, Clinical-stage Biotech, Viral Therapy, Immunotherapies, Clinical Trials, Cancer Research, Cancer Therapy, Personalized Medicine | Oncology, Cancer Therapy, Tumor Treating Fields, Glioblastoma Treatment, Neuro-oncology, Clinical Trials, Global Operations, Innovative Therapies, Cancer Research, Anti-mitotic Treatment |
| Website | ||
| Website | genelux.com | novocure.com |
About Genelux
Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, and Health Care industries, focusing on oncolytic immunotherapy to improve patient outcomes in cases o...
About Novocure
Novocure is a global oncology company with the mission of extending survival in aggressive forms of cancer. The company's innovative therapy, Tumor Treating Fields, is aimed at making a difference in cancer treatment. Novocure's commercialized products are approved in certain countries for the treat...
We will tell you when either one moves
BounceWatch watches Genelux and Novocure for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Genelux and Novocure — by email.
Frequently Asked Questions
Compare Genelux with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Genelux on 2 Apr 2026, and Novocure on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.